Claybrook Capital’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-1,817
| Closed | -$244K | – | 134 |
|
|
2022
Q3 | $244K | Hold |
1,817
| – | – | 0.15% | 114 |
|
|
2022
Q2 | $278K | Hold |
1,817
| – | – | 0.16% | 110 |
|
|
2022
Q1 | $295K | Hold |
1,817
| – | – | 0.15% | 111 |
|
|
2021
Q4 | $246K | Buy |
+1,817
| New | +$246K | 0.12% | 125 |
|
|
2021
Q3 | – | Sell |
-11,601
| Closed | -$1.31M | – | 126 |
|
|
2021
Q2 | $1.31M | Buy |
+11,601
| New | +$1.31M | 0.43% | 68 |
|
|
2019
Q1 | – | Sell |
-62,003
| Closed | -$5.72M | – | 93 |
|
|
2018
Q4 | $5.72M | Buy |
62,003
+60,403
| +3,775% | +$5.57M | 1.6% | 12 |
|
|
2018
Q3 | $151K | Hold |
1,600
| – | – | 0.09% | 82 |
|
|
2018
Q2 | $148K | Hold |
1,600
| – | – | 0.09% | 81 |
|
|
2018
Q1 | $151K | Buy |
1,600
+400
| +33% | +$37.8K | 0.1% | 79 |
|
|
2017
Q4 | $116K | Buy |
+1,200
| New | +$116K | 0.08% | 91 |
|